
The University of Oxford has announced that it will benefit from Nightingale Health’s biomarker analysis technology. The Finnish company will …
Trio become latest Symbiosis commercial additions
UK immunoglobulin supply faces growing pressure, report warns
How will biomarker-led diagnostics reshape respiratory medicine?

